Section 4.2 - Addition of text "The dose can be repeated if necessary after 30 to 60 minutes" unders sub-headings 'In status epilepticus or epileptic convulsions' (adults & children)
Section 4.3 - Minor text amendments. Addition of 'severe hepatic insufficiency'. 'Myasthenia gravis' transferred to section 4.4.
Section 4.4 - Addition of text regarding the following - CNS effects of benzodiasepines on elderly and debilitated patients, amnesia and benzyl alcohol poisoning in infants and children. Addition of sodium and ethanol warnings as per guidelines. 'Myasthenia gravis' transferred from section 4.3.
Section 4.5 - Section re-structured into sub-headings. Addition of text under sub-headings 'Anaesthetics', 'Antidepressants', 'Antiepileptics', 'Antipsychotics' and 'Antivirals'. Addition of 'Digoxin'.
Section 4.8 - Section re-structured into sub-headings. Removal of 'double vision', 'increased apetite', 'laryngeal spasm' and 'menstrual disturbances' (no longer substantiated/justified). Additon of text under sub-heading 'CNS', 'Neurological', 'Psychiatric' and 'Withdrawal Symptoms'. Addition of 'gynaecomastia'.
Section 4.9 - Addition of text unders sub-heading 'Symptoms' regarding impairment of consciousness, respiratory depression and cardiac rate and rhythm (mild overdose), deep coma (severe overdose) and insomnia and major convulsions (as drug levels fall). Addition of text under sub-heading 'Treatment' regarding the use of activated charcoal.
|